Main limitations: Samples used were post-mortem and thus postmortem changes affecting the results cannot be ruled out.
University College London, Institute of Orthopaedics and Musculoskeletal Science, Stanmore, Middlesex, HA7 4LP, UK; 4 Queen Mary University of London, UK. Email: danaez@liv.ac.uk. Background: Tendon injuries remain a common problem in horses and mainly occur in energy-storing tendons, such as the equine superficial digital flexor tendon (SDFT). The inter-fascicular matrix (IFM) of tendons has been demonstrated to be a key determinant of mechanical properties and to be specialised for its function in the high-strain energy-storing SDFT [1].
Objectives: We hypothesised that the IFM is optimised in the SDFT in the post-natal period.
Study design:
We assessed the biomechanical properties of the fascicles and IFM of the SDFT and the positional common digital extensor tendon (CDET) through development and characterised the proteome of the SDFT fascicular matrix (FM) and IFM through development.
Methods: Tendons were collected from fetuses and foals 0-2 years, euthanised for reasons unrelated to this project. Samples were collected following owner's consent or from an abattoir as by-product of the agricultural industry (under the Animal (Scientific Procedures) Act 1986). Fascicles and IFM were dissected and tested biomechanically using an electrodynamic testing machine. Proteome characterisation was performed on laser-captured microdissection of FM and IFM following liquid chromatography-mass spectrometry.
Results: Biomechanical analysis revealed changes through development mainly in the SDFT IFM with a significant interaction between tendon and age for force and extension at maximum stiffness, with the SDFT showing higher values than the CDET with development. Fascicles' properties were similar between tendons through development. Proteomic analysis showed most proteins' abundance in the IFM increased with development and peaked at 3-6 months whereas fascicles' proteins' abundance mainly peaked in fetus and then decreased.
Main limitations: Additional samples would contribute to a more detailed timeline of developmental changes.
Conclusions: These results highlight the importance of the IFM in the function of the energy-storing SDFT and support the post-natal specialisation of the SDFT IFM. Study design: In vitro cell culture.
Methods: MSC from bone marrow (BM), adipose tissue (AT), peripheral blood (PB) from five horses. Cells (p3) were cultured in DMEM + 2% FCS + 1% penicillin/streptomycin + 50 lg/mL gentamicin (only AT) + 10-11 M dexamethasone (only PB) until 70-80% confluence. Four treatment protocols for 48 h: Interleukin-1b (IL-1b) 10 ng/mL, tumour necrosis factora (TNFa) 50 ng/mL, serum amyloid A (SAA) 1 lg/mL, untreated controls. Effect was evaluated using quantitation of mRNA expression of inflammation regulatory markers: IL-1b, IL-6, TNFa, SAA, cyclooxygenase 2 (COX2), hypoxia-inducible factor 1a, transforming growth factor b. Cell types were compared by two-way ANOVA and Tukey's post-test with significance level P<0.05.
Results: Control cultures showed low expression of inflammatory markers. All cell types were affected by treatment with strongest effect of IL-1b. SAA showed limited effect. Expression pattern of IL-1b, IL-6, TNFa, SAA, and COX2 varied markedly between cell types, e.g. COX2 expression was significantly increased in BM and AT but not PB after IL1b treatment, but only in PB after TNFa treatment.
Main limitations: In vitro study.
Conclusions: This is the first direct comparison of response between clinically relevant MSC. Our findings support previous evidence that MSC are affected by inflammation, but also shows that different MSC are not affected equally. Choice of cell type for treatment could depend not only on injury type and tissue, but also presence of inflammation. Further studies are required to determine consequences on regenerative capability. 
